DNA scavengers break down antibiotic-resistant genes

For nearly a century, scientists have waged war on antibiotic-resistant microbes. Michigan State University researchers say they’ve found a new way to prevent it – by unleashing “DNA scavengers” in wastewater treatment plants.

Regeneron and Sanofi’s Dupixent bags fifth drug label in Japan – Pharmaceutical Technology

Share this article Dupixent has been approved as a treatment for chronic spontaneous urticaria (CSU) in patients aged 12 and older whose symptoms are inadequately

February 16, 2024

Q&A: Sanofi’s R&D head reflects on his first year, a post-Dupixent future, and finding an identity

Almost a year ago, Sanofi made history for the wrong reasons. Last October, CEO Paul Hudson announced strategic changes including boosting R&D spending and pulling

October 17, 2024

Amy Abernethy to step down as Verily’s chief medical officer in latest departure from company

Amy Abernethy, the president of product development and chief medical officer at Verily, a health care spinout of search giant Alphabet, will leave the company

December 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.